Intel's capex increase benefits ASML and ASMI

Overview

This report discusses the impact on European semiconductor equipment companies ASML Holding NV and ASM International NV after Intel raised its capex plan on its earnings call. Intel stated that, due to strong demand, its 2026 capex outlook will exceed $20 billion, significantly above expectations at the beginning of the year; at the same time, 2026 equipment spending is expected to grow 40% versus 2025, with a focus on front-end tools for advanced nodes such as Intel 3, 18A, 18A-P, and 14A.

Core views

The core view is that Intel's capex upgrade will mainly benefit ASML and ASMI. ASMI benefits from increased investment intensity by Intel in advanced nodes, especially 18A and 14A; the report estimates that, relative to Intel 3, Intel 14A's serviceable market for ASMI per equivalent 1k wpm of capacity is about 40% higher. ASML benefits from rising demand for Intel low-NA EUV and improved pricing power, although the report does not yet adjust forecasts because higher demand may already be approaching the boundary of ASML's deliverable capacity.

Analysis framework

The report uses an event-driven industry impact analysis: it first identifies the change in Intel's capex guidance, then breaks down spending allocation into front-end tools and advanced process nodes, and finally maps this to ASML's and ASMI's historical customer revenue exposure, equipment demand, serviceable market, and potential pricing/margin impact.

Methodology notes

• Event-driven analysisCapex upgrade transmission

  Changes in customer capex are transmitted to equipment suppliers' orders and revenue expectations

  Intel's higher capex and concentration on front-end tools for advanced process nodes imply that relevant equipment suppliers' order visibility and revenue expectations may be revised upward.

• Industry supply-demand analysisComparison of equipment intensity across advanced nodes

  Differences in equipment serviceable market across process nodes

  The report compares Intel 14A with the Intel 3 node and estimates that ASMI's serviceable market per equivalent 1k wpm of capacity at the 14A node is about 40% higher.

• Profitability analysisPrice and scale efficiency

  Demand intensity supports pricing and margins

  The report believes stronger Intel EUV demand reinforces ASML's pricing power, and as shipment scale rises, efficiency improvement and pricing dynamics may support near-term margin expansion.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• ASML Holding NV (ASML.AS)

  Direct beneficiary of Intel advanced-node capacity expansion and EUV equipment demand

  Strengths

  Low-NA EUV tool demand may exceed the original model, Intel demand reinforces pricing confidence; rising scale helps improve efficiency and margins.

  Weaknesses

  Near-term upside may be limited by ASML's deliverable capacity, so the report has not yet adjusted forecasts.

  Comparison

  Compared with ASMI, ASML's benefit is more concentrated in EUV tool demand, delivery capacity, and pricing dynamics.

  Risks

  Intel order timing below expectations, ASML delivery bottlenecks, delays in advanced-node progress, or weaker-than-expected pricing improvement.

• ASM International NV (ASMI.AS)

  Beneficiary of higher Intel front-end tool investment and increased equipment intensity at advanced nodes

  Strengths

  Intel has historically been a more-than-10% customer; the tilt toward 18A and 14A investment is particularly favorable for ASMI; 14A's serviceable market is about 40% higher than Intel 3.

  Weaknesses

  High sensitivity to the pace of Intel advanced-node capex.

  Comparison

  Compared with ASML, ASMI's benefit is more tilted toward expansion of the serviceable market for advanced-node front-end process equipment and upward pressure on revenue forecast revisions.

  Risks

  Intel capex deployment below expectations, reduced 14A de-risking or delayed ramp timing, and order volatility from customer concentration.

• Intel

  Source of demand and event trigger for the capex upgrade

  Strengths

  Strong demand, with existing fab and cleanroom capacity well positioned, and more incremental capex directed toward tools.

  Weaknesses

  High capex requires advanced nodes to progress on schedule and generate returns.

  Comparison

  Intel is not the main rating subject of this report, but changes in its capex are the core variable in the investment thesis for ASML and ASMI.

  Risks

  Delays in 18A, 18A-P, or 14A node progress, or adjustments to the high 2027 capex plan.

Key data

• Intel 2026 capex outlook> $20bnIntel stated on its earnings call that, due to strong demand, its 2026 capex outlook is significantly above expectations at the beginning of the year.
• Intel 2026 equipment spending growth+40% y/yEquipment spending is expected to increase 40% versus 2025, with a focus on front-end tools.
• Intel 2027 capex directionSignificantly above 2026The report cites Joe Moore forecasting about $30bn.
• ASMI historical revenue exposure to Intel>10%Morgan Stanley estimates Intel has consistently been a more-than-10% customer for ASMI; an earlier model estimated Intel accounted for 18% of ASMI revenue in 2022.
• ASMI 2026/2027 forecast growth2026 +15%; 2027 +35%The report says the current model forecasts modest growth of 15% in 2026 and more pronounced growth of 35% in 2027.
• ASMI serviceable market of Intel 14A relative to Intel 3About 40% higherMeasured per equivalent 1k wpm of capacity.
• ASML low-NA EUV shipment model to IntelFY26 1 unit, FY27 6 unitsThe report says the current model is 1 unit this year and 6 units next year.
• Intel potential low-NA EUV demand this year2 to 4 unitsThe report believes an earlier launch of 14A could bring Intel's demand this year to 2 to 4 units, but it does not yet adjust estimates.

Impact & implications

The investment implication is positive: Intel's advanced-node investment reinforces the order and pricing logic for the European semiconductor equipment chain. ASMI may receive higher demand for front-end deposition/related tools, while ASML may benefit from earlier low-NA EUV demand and pricing resilience. The constraint is that ASML's near-term delivery capacity may limit upside realization, while at the industry level Morgan Stanley still maintains an In-Line view.

Risks

• ASML's near-term delivery capacity may limit fulfillment of Intel's incremental demand.
• If Intel's advanced-node 18A, 18A-P, and 14A rollout is delayed, order pull-through for ASML and ASMI will weaken.
• Intel's capex plan may change with demand, cash flow, or strategic adjustments.
• Morgan Stanley discloses that it has investment banking or potential business relationships with multiple covered companies, and investors should pay attention to conflict-of-interest disclosures.

What to watch

• Whether Intel subsequently confirms capex above $20 billion in 2026 and the specific amount for a significantly higher 2027 level.
• Whether Intel 14A de-risking and the 2028 high-volume production ramp plan proceed on schedule.
• Whether ASML's actual low-NA EUV tool shipments to Intel are revised up from 1 unit to the 2 to 4 unit range.
• Whether ASMI's Intel orders, revenue share, and 2027 growth expectations continue to be revised upward.
• Whether ASML's price increases and margin improvement are realized in upcoming results.